Amanote Research
Register
Sign In
Psy139 - Current Use of Factor Viii Products in Children and Adolescents With Moderate or Severe Haemophilia A
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2713
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
C. Hirst
S. Kessabi
R. Farej
R. Aubert
J. Yao
T. Burke
J. O`Hara
Publisher
Elsevier BV
Related search
Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII
BMJ
Transfusion Requirements of Adolescents With Severe Haemophilia A.
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Identification of a Novel Mutation in the Factor VIII Gene Causing Severe Haemophilia A
BMC Hematology
Hematology
Molecular Biology
Better Adherence to Prescribed Treatment Regimen Is Related to Less Chronic Pain Among Adolescents and Young Adults With Moderate or Severe Haemophilia
Haemophilia
Medicine
Genetics
Hematology
Long-Term Analysis of the Benefit of Prophylaxis for Adult Patients With Severe or Moderate Haemophilia A
Haemophilia
Medicine
Genetics
Hematology
Prevalence of Inhibitors to Factor VIII After 25 Exposures to Factor VIII Concentrates and/or Blood Products in Persons With Hemophilia A
Journal of Medical Science And Clinical Research
Diagnosis of Haemophilia: Use of an Artificial Factor-Viii-Deficient Human Plasma System
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Factor XIa-triggered Thrombin Generation in Severe Haemophilia A
British Journal of Haematology
Hematology
Adherence to Prophylaxis in Adolescents and Young Adults With Severe Haemophilia: A Quantitative Study With Patients
PLoS ONE
Multidisciplinary
